These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30130793)

  • 1. A Pilot Trial to Quantify Plasma Exosomes in Colorectal Cancer Screening from the International Collaborative Study between Chile and Japan.
    Kobayashi M; Kawachi H; Hurtado C; Wielandt AM; Ponce A; Karelovic S; Pasternak S; Delgado C; Pinto P; Carrasco H; Ito T; Okada T; Tanaka K; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Digestion; 2018; 98(4):270-274. PubMed ID: 30130793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic study from a colorectal cancer screening in Chile: results from the first 2 years of an international collaboration between Chile and Japan.
    Kobayashi M; Kawachi H; Pasternak S; Delgado C; Pinto P; Ito T; Karelovic S; Carrasco H; Tanaka K; Okada T; Odagaki T; Zárate AJ; Ponce A; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Eur J Cancer Prev; 2019 Jul; 28(4):245-253. PubMed ID: 29958195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening.
    Okada T; Tanaka K; Kawachi H; Ito T; Nishikage T; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Karelovic S; Flores S; Estela R; Tsubaki M; Uetake H; Eishi Y; Kawano T
    Cancer; 2016 Jan; 122(1):71-7. PubMed ID: 26445309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a multicentric colorectal cancer screening program in Chile].
    López-Kostner F; Zárate AJ; Ponce A; Kronberg U; Kawachi H; Okada T; Tsubaki M; Ito T; Nishikage T; Tanaka K; Kawano T; Eishi Y; Peñaloza P; Estela R; Karelovic S; Flores S
    Rev Med Chil; 2018 Jun; 146(6):685-692. PubMed ID: 30148899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer risk factors in asymptomatic Chilean population: a survey of international collaboration between Japan and Chile.
    Okada T; Odagaki T; López-Köstner F; Zárate AJ; Ponce A; Kronberg U; Karelovic S; Flores S; Estela R; Ito T; Yasuno M; Uetake H; Kojima K; Kitagawa M
    Eur J Cancer Prev; 2020 Mar; 29(2):127-133. PubMed ID: 31436751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
    Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
    Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
    Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
    Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
    Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
    Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
    Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
    Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
    Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
    Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
    Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
    J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.